Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole

Medicine and Dentistry

• Hydroxymethylglutaryl Coenzyme A Reductase Kinase Activator 100%
• Dipyridamole 100%
• Phosphodiesterase Inhibitor 100%
• 5 Amino 4 Imidazolecarboxamide 66%
• Guanylate Cyclase 50%
• Vidarabine 33%
• Vasodilator Stimulated Phosphoprotein 16%
• Cyclic GMP Dependent Protein Kinase 16%
• Protein Kinase Inhibitor 16%
• Guanylate Cyclase Inhibitor 16%
• 1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One 16%
• Nitric Oxide Synthase Inhibitor 16%
• Artery Occlusion 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Phosphodiesterase Inhibitor 100%
• Dipyridamole 100%
• Guanylate Cyclase 50%
• Vidarabine 33%
• Protein Kinase Inhibitor 16%
• 1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One 16%
• Nitric Oxide Synthase Inhibitor 16%
• Guanylate Cyclase Inhibitor 16%
• Artery Occlusion 16%
• Vasodilator Stimulated Phosphoprotein 16%
• Cyclic GMP Dependent Protein Kinase 16%